FDA approves pirtobrutinib for untreated CLL/SLL without 17p deletion based on BRUIN CLL-313 data. Read key nursing safety takeaways.
|Videos|January 29, 2017
Monoclonal Antibodies in Multiple Myeloma
Author(s)Keith Stewart, MB, ChB
Keith Stewart, MB, ChB from Mayo Clinic in Scottsdale, discusses the use of monoclonal antibodies for treatment in multiple myeloma.
Advertisement
Keith Stewart, MB, ChB from Mayo Clinic in Scottsdale, discusses the use of monoclonal antibodies for treatment in multiple myeloma.
The two monoclonal antibodies currently approved for treatment in patients with multiple myeloma are elotuzumab and daratumumab. While infusion reactions can occur with these treatments, there are pre-medications recommended. Additionally, most reactions are not usually experienced beyond the first infusion.
To learn more about these treatments, watch
Advertisement
Related to this article
Most oral blood cancer drug prescriptions were first rejected by insurers, and fill rates fell sharply when out-of-pocket costs topped $175.
At ASTRO 2026, Suresh Rana details how AI-driven contouring accelerates care timelines, requiring rigorous team monitoring and early nursing input.
At ASTRO 2026, Dr. Erica Braschi Jordan details toxicity tracking, physical therapy referral, and quality of life in proton regional nodal irradiation.
At ASTRO 2026, Dr. Mishaal Munir details how nurse-led triage workflows and prompt symptom escalations improve care for breast cancer brain metastases.
ASTRO 2026 presenter Kayla Kafka-Peterson details an Adapt-Adopt-Build model to bridge global brachytherapy nursing gaps and standardize perioperative care.
At ASTRO 2026, Dr. Nitin Ohri details additive versus synergistic toxicities when combining radiation with novel systemic therapies in clinical trials.
APHON 2026 speaker Amy C. Haskamp, CNS, discusses tiered self-care tactics and boundaries to help pediatric oncology nurses navigate emotional distress and burnout.
Advertisement
Advertisement
Trending on Oncology Nursing News
1
The Importance of Precise Clinical Communication in Oncology Nursing
2
FDA Approves Pirtobrutinib for Untreated CLL/SLL
3
Balancing Treatment Efficacy and Quality of Life in Metastatic Triple-Negative Breast Cancer
4
ASTRO 2026: Dr. Erica Braschi Jordan Details Proton Regional Nodal Care Plan
5